Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Common Respiratory Disorders01:31

Common Respiratory Disorders

961
Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
961
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

640
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
640
Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

384
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
384
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

362
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
362
Upper Respiratory Drugs: First and Second-Generation Antihistamines01:15

Upper Respiratory Drugs: First and Second-Generation Antihistamines

484
Antihistamines are a class of drugs widely used to alleviate the symptoms of allergies, such as sneezing, itching, and nasal congestion. They work by inhibiting the actions of histamine, which is released by immune cells in response to allergenic substances or tissue injuries.
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
484
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

399
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
399

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ESCMID Global Congress 2026.

The Lancet. Microbe·2026
Same author

2026 American Thoracic Society International Conference.

The Lancet. Respiratory medicine·2026
Same author

2026 GINA report for asthma.

The Lancet. Respiratory medicine·2026
Same author

SCCM 2026 guidelines: caring for older adults in the ICU.

The Lancet. Respiratory medicine·2026
Same author

Nipah virus outbreaks in south Asia.

The Lancet. Microbe·2026
Same author

UK trials AI and robotics to detect lung cancer earlier.

The Lancet. Respiratory medicine·2026

Related Experiment Video

Updated: Sep 23, 2025

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

16.2K

Nirsevimab: a promising therapy for RSV

Priya Venkatesan

    The Lancet. Microbe
    |May 11, 2022
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
    09:14

    An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

    Published on: January 26, 2019

    11.1K
    An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
    09:01

    An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

    Published on: December 10, 2013

    8.0K

    Related Experiment Videos

    Last Updated: Sep 23, 2025

    Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
    11:48

    Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

    Published on: April 4, 2019

    16.2K
    An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
    09:14

    An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

    Published on: January 26, 2019

    11.1K
    An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
    09:01

    An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

    Published on: December 10, 2013

    8.0K